Robert J. Adelman, 10% Owner at Elevation Oncology, Inc. (ELEV), sold 1,405,474 shares at $4.12 ($5.8M) on 2022-05-25, disclosed to the SEC on 2022-05-27.
Open-market sale of $5.8M ELEV by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.12 | 702,737 | $2.9M | 50.0% |
| 2 | $4.12 | 702,737 | $2.9M | 50.0% |
| Total | $4.12 avg | 1,405,474 | $5.8M | 100% |
| Filing → |
| AKRO | SELL | 2020-01-06 | $1.4M | — | Filing → |
| ARYX | BUY | 2007-11-14 | $3.0M | — | Filing → |